middle.news
Racura Oncology Secures $34.3 Million to Fully Fund Three Cancer Trials
12:36pm on Tuesday 16th of June, 2026 AEST
•
Healthcare
Read Story
Racura Oncology Secures $34.3 Million to Fully Fund Three Cancer Trials
12:36pm on Tuesday 16th of June, 2026 AEST
Key Points
Total $34.3 million capital raised from options and placements
Funds to fully finance RC220 trials in AML, EGFRm NSCLC, and cardioprotection
Partial placement of shortfall options to limit dilution
No broker or underwriter fees paid
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Racura Oncology (ASX:RAC)
OPEN ARTICLE